Based on the TCGA cohort of HNSCC, GALR1 and SALL3 mutations occurred at low frequencies, in three (0.58%) and nine (1.75%) of 515 patients, respectively [16]. The gene discussed is GALR1; the disease is head and neck squamous cell carcinoma.